Section Arrow
Quote
CURX.NASDAQ
- Curanex Pharmaceuticals Inc.
(Financial Status)
Quotes are at least 15-min delayed:2026/03/09 18:58 EDT
After Hours
Last
 0.3726
-0.0173 (-4.44%)
Bid
0.3722
Ask
0.39
High 0.4014 
Low 0.3715 
Volume 646 
Regular Hours (Closed)
Last
 0.3899
-0.0081 (-2.04%)
Day High 
0.4014 
Prev. Close
0.398 
1-M High
0.6666 
Volume 
426.56K 
Bid
0.3722
Ask
0.39
Day Low
0.3715 
Open
0.3929 
1-M Low
0.2713 
Market Cap 
11.28M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.4 
20-SMA 0.35 
50-SMA 0.35 
52-W High 9.1796 
52-W Low 0.262 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.05/--
Enterprise Value
11.28M
Balance Sheet
Book Value Per Share
0.50
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ANTXAN2 Therapeutics5.25+2.41+84.86%-- 
After Hours 5.07 -0.18 -3.43%
RLMDRelmada Therapeutics7.17+2.72+61.12%-- 
After Hours 6.87 -0.3 -4.18%
IOVAIovance Biotherapeutics5.41+0.275+5.36%-- 
After Hours 5.41 0 0.00%
IBRXImmunityBio8.45-0.2-2.31%-- 
After Hours 8.4 -0.05 -0.59%
QNCXQuince Therapeutics0.1065+0.0042+4.11%-- 
After Hours 0.1058 -0.0007 -0.66%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.